Recall Atlas

Drugs & medical recalls in Canada in 2024

643 official drugs & medical recalls in Canada reported in 2024, from Health Canada, the CFIA and Transport Canada. Newest first. Search by product, brand or hazard.

Updated –– recalls in the last 60 daysRSS feedGet the app

Recalls in 2024

643

By month

JanJunDec

Drugs & medical recalls in Canada in 2024

  1. 2024-12-31
  2. CA
    Drugs & medicalType II

    Single Use Mechanical Lithotriptor V

    Performance

    Health CanadaOfficial notice →
  3. CA
    Drugs & medicalType II

    Level 1® I.V. Pole With Flanking Brackets

    Device compatibility

    Health CanadaOfficial notice →
  4. CA
    Drugs & medicalType II

    Brivo NM 615 - Main Unit

    Performance

    Health CanadaOfficial notice →
  5. 2024-12-30
  6. CA
    Drugs & medicalType II

    Iris X80, X90, and PXL Intra-Oral Cameras

    Unauthorised device

    Health CanadaOfficial notice →
  7. CA
    Drugs & medicalType I

    PMS-CINACALCET: Affected lots may exceed the established acceptable intake limit for N-nitroso-cinacalcet.

    Product safety

    Health CanadaOfficial notice →
  8. CA
    Drugs & medicalType II

    Smartdrive Mx2+ Power Assist

    Performance

    Health CanadaOfficial notice →
  9. CA
    Drugs & medicalType II

    Panther Fusion® GBS Assay

    Performance

    Health CanadaOfficial notice →
  10. CA
    Drugs & medicalType II

    Azurion and Allura Systems

    Performance

    Health CanadaOfficial notice →
  11. CA
    Drugs & medicalType II

    Idylla Instrument

    Performance

    Health CanadaOfficial notice →
  12. CA
    Drugs & medicalType II

    Coloplast Catheters

    Labelling and packaging - Sterility

    Health CanadaOfficial notice →
  13. 2024-12-27
  14. CA
    Drugs & medicalType I

    Forceps/Irrigation Plug

    Device compatibility

    Health CanadaOfficial notice →
  15. 2024-12-24
  16. CA
    Drugs & medicalType II

    QAngio XA 3D

    Performance

    Health CanadaOfficial notice →
  17. CA
    Drugs & medicalType I

    Neo-Tee T-Piece Resuscitator

    Performance

    Health CanadaOfficial notice →
  18. 2024-12-23
  19. CA
    Drugs & medicalType II

    Jamp Amoxi Clav Suspension; Out of specification

    Product quality

    Health CanadaOfficial notice →
  20. 2024-12-20
  21. CA
    Drugs & medicalType II

    TEVA-Codeine Tablets: out of specification on friability test (broken tablet) during stability testing for affected lots.

    Product safety

    Health CanadaOfficial notice →
  22. 2024-12-19
  23. CA
    Drugs & medicalType II

    DLP™ Elongated One Piece Arterial Cannulae

    Labelling and packaging

    Health CanadaOfficial notice →
  24. CA
    Drugs & medicalType II

    Vitros® Chemistry Products System - DGXN Slides (Digoxin)

    Labelling and packaging

    Health CanadaOfficial notice →
  25. CA
    Drugs & medicalType II

    Biodesign® Hiatal Hernia Graft

    Labelling and packaging

    Health CanadaOfficial notice →
  26. CA
    Drugs & medicalType II

    Medtronic Fixator Pins - Stainless Steel

    Device compatibility

    Health CanadaOfficial notice →
  27. 2024-12-18
  28. CA
    Drugs & medicalType II

    OEC Elite and OEC Mobile C-arms

    Performance

    Health CanadaOfficial notice →
  29. CA
    Drugs & medicalType II

    Maquet Hemoconcentrator Set With Softline Coating

    Performance

    Health CanadaOfficial notice →
  30. CA
    Drugs & medicalType II

    Optima XR220amx X-Ray System

    Performance

    Health CanadaOfficial notice →
  31. CA
    Drugs & medicalType II

    Change Healthcare Cardiology Hemo

    Performance

    Health CanadaOfficial notice →
  32. CA
    Drugs & medicalType II

    AVVIGO™+ Multi-Modality Guidance System

    Performance

    Health CanadaOfficial notice →
  33. 2024-12-17
  34. CA
    Drugs & medicalType II

    Silvercel Hydro-Alginate Antimicrobial Dressing

    Sterility

    Health CanadaOfficial notice →
  35. 2024-12-16
  36. CA
    Drugs & medicalType III

    ANTIHISTAMINE ORAL: The affected lot may contain concentrations of Ephedrine Hydrochloride and Pyrilamine Maleate that are outside the labeled concentration.

    Product safety

    Health CanadaOfficial notice →
  37. 2024-12-12
  38. CA
    Drugs & medicalType II

    Vitamin A acid: The dosage of tretinoin is out of specification in the affected batch.

    Product safety

    Health CanadaOfficial notice →
  39. CA
    Drugs & medicalType II

    Medline Industries Kits containing Non-Sterile Codman Surgical Patties and Strips produced by Integra Lifesciences

    Sterility

    Health CanadaOfficial notice →
  40. CA
    Drugs & medicalType II

    Datex-Ohmeda Tec-6 Plus and Tec 850 Anesthetic Vaporizors

    Performance

    Health CanadaOfficial notice →
  41. CA
    Drugs & medicalType II

    Epoc NXS Host - 5553CA

    Performance

    Health CanadaOfficial notice →
  42. 2024-12-11
  43. CA
    Drugs & medicalType II

    Blueprint Mixed Reality BP MxR Glenoid Pin Guide

    Performance

    Health CanadaOfficial notice →
  44. CA
    Drugs & medicalType II

    3M Transbond Plus Self Etching Primer

    Performance

    Health CanadaOfficial notice →
  45. CA
    Drugs & medicalType II

    Zeus Infinity Empowered

    Performance

    Health CanadaOfficial notice →
  46. 2024-12-10
  47. CA
    Drugs & medicalType II

    BD FACSLyric Flow Cytometer

    Performance

    Health CanadaOfficial notice →
  48. CA
    Drugs & medicalType II

    Bard Magnum Core Tissue Biopsy Needle

    Sterility

    Health CanadaOfficial notice →
  49. 2024-12-09
  50. CA
    Drugs & medicalType II

    SANDOZ FESOTERODINE FUMARATE: The Diester impurity is out of specification in the affected lot(s)

    Product safety

    Health CanadaOfficial notice →
  51. 2024-12-06
  52. CA
    Drugs & medicalType II

    Absorbine Jr. Extra Strength Multi Use Patch: Voluntary recall due to significant violations to the GMPs

    Product quality

    Health CanadaOfficial notice →
  53. CA
    Drugs & medicalType II

    Perfusion Set With Bioline Coating

    Labelling and packaging

    Health CanadaOfficial notice →
  54. CA
    Drugs & medicalType II

    Merlin PCS 3330 Software Upgrade Kit

    Performance

    Health CanadaOfficial notice →
  55. 2024-12-05
  56. CA
    Drugs & medicalType II

    IPANA 20% BENCOCAINE TOPICAL GEL: Affected lot may contain the presence of metal contaminants.

    Product safety

    Health CanadaOfficial notice →